| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.01 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |